Skip to main content
. Author manuscript; available in PMC: 2014 May 29.
Published in final edited form as: Clin Chem. 2013 Oct 21;60(1):233–242. doi: 10.1373/clinchem.2013.211953

Figure 6. Profiles of the potential peptide signatures in healthy woman plasma and woman patients’ plasma with breast cancer of different pathological stages.

Figure 6

Sample number: n = 10, healthy controls; n = 11, stage I breast cancer (BC-I); n = 12, stage II breast cancer (BC-II); n = 15, stage III breast cancer (BC-III); n = 10, stage IV breast cancer (BC-IV); Student’s t-test, * p < 0.05, *** p < 0.001.